Neuron-specific age-related decreases in dopamine receptor subtype mRNAs

Journal of Comparative Neurology

Volumn 456, Issue 2, 2003, Pages 176-183

  Hemby, Scott E ^a,d   Trojanowski, John Q ^b   Ginsberg, Stephen D ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Aging; Entorhinal cortex; Gene expression; Hippocampus; Indexing terms; Microarray

Indexed keywords

BETA ACTIN; DOPAMINE RECEPTOR; MESSENGER RNA; TAU PROTEIN;

ADULT; AGE; AGED; ARTICLE; BEHAVIOR DISORDER; BRAIN; CADAVER; CELL ASSAY; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DOPAMINERGIC SYSTEM; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEARNING; MALE; MEMORY; NERVE CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PSYCHOSIS; PYRAMIDAL NERVE CELL; RNA ANALYSIS; SENESCENCE; STELLATE CELL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION PROFILING; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, DOPAMINE; REFERENCE VALUES; RNA, MESSENGER;

EID: 0037415316     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10525     Document Type: Article

References (58)

1. Akil M, Edgar CL, Pierri JN, Casali S, Lewis DA. 2000. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol Psychiatry 47:361-370.
2. Amenta F, Mignini F, Ricci A, Sabbatini M, Tomassoni D, Tayebati SK. 2001. Age-related changes of dopamine receptors in the rat hippocampus: A light microscope autoradiography study. Mech Ageing Dev 122:2071-2083.
3. 11C]-raclopride. Ann N Y Acad Sci 695:81-85.
4. Antonini A, Vontobel P, Psylla M, Gunther I, Maguire PR, Missimer J, Leenders KL. 1995. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch Neurol 52:1183-1190.
5. Bannon MJ, Whitty CJ. 1997. Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48:969-977.
6. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G. 1992. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci USA 89:7095-7099.
7. 123I]epidepride single photon emission tomography (SPET) study. Psychopharmacology 150:132-140.
8. Camps M, Cortes R, Gueye B, Probst A, Palacios JM. 1989. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites. Neuroscience 28:275-290.
9. Ciliax BJ, Hersch SM, Levey AI. 1994. Immunocytochemical localization of D1 and D2 receptors in rat brain. In: Niznik HB, editor. Dopamine Receptors and Transporters. New York: Marcel Dekker. p 383-400.
10. Cortes R, Gueye B, Pazos A, Probst A, Palacios JM. 1989. Dopamine receptors in human brain: Autoradiographic distribution of D1 sites. Neuroscience 28:263-273.
11. Drachman DA. 1997. Aging and the brain: A new frontier. Ann Neurol 42:819-828.
12. Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, Coleman P. 1992. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89:3010-3014.
13. Eberwine J, Crino P, Arnold S, Trojanowski J, Hemby S. 1998. Molecular analysis of the single cell: Importance in the study of psychiatric disorders. In: Watson SJ, editor. Psychopharmacology: Fifth Generation of Progress [CD-ROM]. New York: Lippincott-Raven Press.
14. Emborg ME, Ma SY, Mufson EJ, Levey AI, Taylor MD, Brown WD, Holden JE, Kordower JH. 1998. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol 401:253-265.
15. Fearnley JM, Lees AJ. 1991. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114:2283-2301.
16. Ginsberg SD, Crino PB, Lee VM, Eberwine JH, Trojanowski JQ. 1997. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann Neurol 41:200-209.
17. Ginsberg SD, Galvin JE, Chiu TS, Lee VM, Masliah E, Trojanowski JQ. 1998. RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathol 96:487-494.
18. Ginsberg SD, Crino PB, Hemby SE, Weingarten JA, Lee VM, Eberwine JH, Trojanowski JQ. 1999. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann Neurol 45:174-181.
19. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ. 2000. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48:77-87.
20. Godefroy F, Bassant MH, Weil-Fugazza J, Lamour Y. 1989. Age-related changes in dopaminergic and serotonergic indices in the rat forebrain. Neurobiol Aging 10:187-190.
21. Goldman-Rakic PS, Brown RM. 1981. Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6:177-187.
22. Hemby SE, Ginsberg SD, Brunk B, Trojanowski JQ, Eberwine JH. 2002. Gene expression profile for schizophrenia: Discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 59:631-640.
23. Ichise M, Ballinger JR, Tanaka F, Moscovitch M, St. George-Hyslop PH, Raphael D, Freedman M. 1998. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med 39:1511-1518.
24. Inoue M, Suhara T, Sudo Y, Okubo Y, Yasuno F, Kishimoto T, Yoshikawa K, Tanada S. 2001. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. Life Sci 69:1079-1084.
25. Iyo M, Yamasaki T. 1993. The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog Neuropsychopharmacol Biol Psychiatry 17:415-421.
26. Joyce JN, Myers AJ, Gurevich E. 1998. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain Res 784:7-17.
27. Kaasinen V, Vilkman H, Hietala J, Nagren K, Helenius H, Olsson H, Farde L, Rinne J. 2000. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging 21:683-688.
28. Kaasinen V, Kemppainen N, Nagren K, Helenius H, Kurki T, Rinne JO. 2002. Age-related loss of extrastriatal dopamine D(2)-like receptors in women. J Neurochem 81:1005-1010.
29. Kane JM, Weinhold P, Kinon B, Wegner J, Leader M. 1982. Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderly. Psychopharmacology 77:105-108.
30. Kubis N, Faucheux BA, Ransmayr G, Damier P, Duyckaerts C, Henin D, Forette B, Le Charpentier Y, Hauw JJ, Agid Y, Hirsch EC. 2000. Preservation ofmidbrain catecholaminergic neurons in very old human subjects. Brain 123:366-373.
31. Leonard BW, Amaral DG, Squire LR, Zola-Morgan S. 1995. Transient memory impairment in monkeys with bilateral lesions of the entorhinal cortex. J Neurosci 15:5637-5659.
32. Ma SY, Ciliax BJ, Stebbins G, Jaffar S, Joyce JN, Cochran EJ, Kordower JH, Mash DC, Levey AI, Mufson EJ. 1999a. Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra. J Comp Neurol 409:25-37.
33. Ma SY, Roytt M, Collan Y, Rinne JO. 1999b. Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing. Neuropathol Appl Neurobiol 25:394-399.
34. Meador-Woodruff JH. 1994. Update on dopamine receptors. Ann Clin Psychiatry 6:79-90.
35. Meador-Woodruff JH, Grandy DK, Van Tol HH, Damask SP, Little KY, Civelli O, Watson SJ Jr. 1994. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10:239-248.
36. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. 1996. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29.
37. Miguez JM, Aldegunde M, Paz-Valinas L, Recio J, Sanchez-Barcelo E. 1999. Selective changes in the contents ofnoradrenaline, dopamine and serotonin in rat brain areas during aging. J Neural Transmiss Gen Sect 106:1089-1098.
38. Muthane U, Yasha TC, Shankar SK. 1998. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43:283-287.
39. Odenheimer G, Funkenstein HH, Beckett L, Chown M, Pilgrim D, Evans D, Albert M. 1994. Comparison of neurologic changes in 'successfully aging' persons vs the total aging population. Arch Neurol 51:573-580.
40. Rinne JO. 1987. Muscarinic and dopaminergic receptors in the aging human brain. Brain Res 404:162-168.
41. Rinne JO, Lonnberg P, Marjamaki P. 1990. Age-dependent decline in human brain dopamine D1 and D2 receptors. Brain Res 508:349-352.
42. 11C]raclopride. J Cereb Blood Flow Metab 13:310-314.
43. Ryoo HL, Joyce JN. 1994. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. J Comp Neurol 348:94-110.
44. Scatton B, Simon H, Le Moal M, Bischoff S. 1980. Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci Lett 18:125-131.
45. Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP, Bird ED, Riederer P, Jellinger K, Watanabe S. 1987. Human brain dopamine receptors in children and aging adults. Synapse 1:399-404.
46. Severson JA, Marcusson J, Winblad B, Finch CE. 1982. Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem 39:1623-1631.
47. Squire LR, Zola-Morgan S. 1991. The medial temporal lobe memory system. Science 253:1380-1386.
48. Surmeier DJ, Song WJ, Yan Z. 1996. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.
49. Tecott LH, Barchas JD, Eberwine JH. 1988. In situ transcription: Specific synthesis of complementary DNA in fixed tissue sections. Science 240:1661-1664.
50. Verney C, Baulac M, Berger B, Alvarez C, Vigny A, Helle KB. 1985. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience 14:1039-1052.
51. 18F-N-methylspiroperidol. Psychiatry Res 67:11-16.
52. Volkow ND, Wang GJ, Fowler JS, Ding YS, Gur RC, Gatley J, Logan J, Moberg PJ, Hitzemann R, Smith G, Pappas N. 1998. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging. Ann Neurol 44:143-147.
53. Volkow ND, Logan J, Fowler JS, Wang GJ, Gur RC, Wong C, Felder C, Gatley SJ, Ding YS, Hitzemann R, Pappas N. 2000. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry 157:75-80.
54. Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M, Huser JM, Snow BJ, Ruth TJ, Calne DB, Stoessl AJ. 1998. Age-dependent decline of dopamine D1 receptors in human brain: A PET study. Synapse 30:56-61.
55. Wong DF, Pearlson GD, Tune LE, Young LT, Meltzer CC, Dannals RF, Ravert HT, Reith J, Kuhar MJ, Gjedde A. 1997. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 17:331-342.
56. Xiberas X, Martinot JL, Mallet L, Artiges E, Loc HC, Maziere B, Paillere-Martinot ML. 2001. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry 179:503-508.
57. Zola-Morgan S, Squire LR. 1993. Neuroanatomy of memory. Annu Rev Neurosci 16:547-563.
58. Zola-Morgan S, Squire LR, Ramus SJ. 1994. Severity of memory impairment in monkeys as a function of locus and extent of damage within the medial temporal lobe memory system. Hippocampus 4:483-495.